Cumulative iron dose and resistance to erythropoietin

Introduction Optimizing anemia treatment in hemodialysis (HD) patients remains a priority worldwide as it has significant health and financial implications. Our aim was to evaluate in a large cohort of chronic HD patients in Fresenius Medical Care centers in Spain the value of cumulative iron (Fe) d...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of nephrology Ročník 28; číslo 5; s. 603 - 613
Hlavní autoři:	Rosati, A., Tetta, C., Merello, J. I., Palomares, I., Perez-Garcia, R., Maduell, F., Canaud, B., Aljama Garcia, P.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Cham Springer International Publishing 01.10.2015 Springer Nature B.V
Témata:	Aged Anemia Anemia - blood Anemia - drug therapy Anemia - etiology Biomarkers - blood C-reactive protein Cardiovascular disease Diabetes Dose-Response Relationship, Drug Drug Resistance Erythropoietin - therapeutic use Female Follow-Up Studies Hemodialysis Hemoglobin Hemoglobins - metabolism Humans Iron Iron - administration & dosage Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Malnutrition Medicine Medicine & Public Health Middle Aged Mortality Nephrology Original Article Patients Renal Dialysis Retrospective Studies Urology Variables Spain Serum Ferritin Level Darbepoetin Alfa Sevelamer Ferritin Iron Overload
ISSN:	1121-8428, 1724-6059, 1724-6059
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!